Verified Beauty Data

Ingredient comparison Nº 42 / Head-to-head

Tranexamic Acid vs Kojic Acid

Both fade dark spots, but they work at opposite ends of the pigment pathway: tranexamic acid is the gentler, better-evidenced choice for melasma; kojic acid is a potent direct tyrosinase inhibitor that shines in combination.

Tranexamic acid and kojic acid are both brighteners, but they attack pigmentation from different directions. Tranexamic acid works upstream and on blood vessels — it calms the keratinocyte signal that tells melanocytes to make pigment after UV or inflammation, and it suppresses VEGF to reduce the redness and vascular component of melasma. That gives it the strongest evidence of any non-hydroquinone topical for melasma, plus a gentle, stable, sensitive-skin-friendly profile. Kojic acid is a classic, direct tyrosinase inhibitor: it chelates the copper at the heart of the melanin-making enzyme, blocking pigment at the enzymatic step. It has real melasma evidence and is a potent, well-understood brightener — but it's chemically unstable (it oxidises yellow-brown and loses potency), carries a higher contact-allergy rate, and is capped at 1% in the EU. So the call depends on the goal: choose tranexamic acid for melasma, redness-prone pigmentation, or sensitive skin; choose kojic acid for a potent direct tyrosinase block, especially as part of a multi-active brightening routine. They're also frequently — and effectively — combined.

02 / Head-to-head

Compared dimension by dimension

Each row shows what the evidence actually says for both ingredients on that dimension. Edge = which ingredient has the stronger case, or "no clear edge" when evidence is comparable or insufficient for a call.

Dimension Tranexamic Acid Kojic Acid Edge
How each one works

Works upstream and on blood vessels, not on the pigment enzyme directly.It calms the keratinocyte plasmin/prostaglandin signal that drives melanocytes to make pigment after UV or inflammation, and it suppresses VEGF to dampen the angiogenesis and erythema component.

12

A direct, classic tyrosinase inhibitor: it chelates the copper ions at the active site of tyrosinase — the rate-limiting enzyme of melanin synthesis — blocking pigment production right at the enzymatic step.

8
No clear edge
Evidence for melasma

The strongest of any non-hydroquinone topical: a meta-analysis of 11 studies (667 participants) found a significant MASI reduction, and a split-face RCT found 3% tranexamic acid as effective as 4% hydroquinone over 8 weeks.

45

Real but thinner: 1% kojic acid monotherapy cut MASI 58% at 12 weeks, and 2% in a combination gel improved clearance — but well-powered standalone trials are fewer, and it's most often used as an adjunct.

910
Advantage: Tranexamic Acid
Redness & the vascular component

Uniquely targets the vascular side of pigmentation: by suppressing VEGF it reduces the angiogenesis and erythema that drive the redness in melasma — an effect a pure tyrosinase inhibitor can't offer.

23

Acts only on pigment, not on blood vessels.As a tyrosinase inhibitor it addresses the brown but has no anti-angiogenic or anti-redness action.

8
Advantage: Tranexamic Acid
Tolerability & sensitisation

Very well tolerated — clinical trials report only rare, transient irritation, and unlike hydroquinone it carries no ochronosis risk, making it a sensible choice for sensitive skin.

54

More likely to cause trouble: kojic acid has a higher contact-sensitisation rate than gentler brighteners, with documented allergic contact dermatitis and even a paradoxical pigmented contact dermatitis (darkening from a lightener).

1112
Advantage: Tranexamic Acid
Stability & formulation

Easy and stable to formulate — it holds above 97% potency for weeks in water, tolerates a broad pH, and doesn't discolour, so the product you buy keeps working.

6

Notoriously unstable: it oxidises on exposure to light, air and iron, turning yellow-brown — a visible sign it has degraded and lost potency — so it needs opaque, airless packaging, and the EU caps it at 1%.

131416
Advantage: Tranexamic Acid
Direct tyrosinase potency & combos

Acts indirectly on the upstream signal rather than the enzyme, and as a water-loving molecule its skin penetration is limited — which is why delivery tech (liposomes, microneedling) is often used to boost it.

7

A potent, direct OTC tyrosinase inhibitor that acts right at the pigment-making enzyme — a well-understood classic brightener and a reliable partner in multi-active brightening formulas.

915
Advantage: Kojic Acid

03 / The decision

Which one is right for you?

Choose Tranexamic Acid if…

  • Your main concern is melasma — especially the kind with visible redness or a flushed, vascular look — and you want the best-evidenced non-hydroquinone option.
  • You have sensitive or reactive skin and want a gentle, stable brightener with no ochronosis risk.
  • You want one ingredient that calms the pigment trigger and the redness, not just the brown.

Choose Kojic Acid if…

  • You want a potent, direct tyrosinase inhibitor that acts right at the pigment-making enzyme.
  • You're building a multi-active brightening routine where kojic acid is a classic, effective partner.
  • You can use a well-packaged (opaque, airless) product, have no history of contact allergy, and will replace it once it discolours.

Shop these actives

Buy The INKEY List on Amazon $18.00 Tranexamic Acid · affiliate link

Buy Kojie San on Amazon $9.93 Kojic Acid · affiliate link

04 / Stacking

Can you use both?

Can you combine Tranexamic Acid and Kojic Acid?

Yes — they're complementary, not competing. Tranexamic acid works on the upstream signal and the blood vessels while kojic acid blocks the tyrosinase enzyme directly, so together they hit different steps of the pigment pathway; a serum combining tranexamic acid, kojic acid and niacinamide improved facial dyschromia in a clinical evaluation. Use a well-formulated combination product or layer them, keep the kojic acid in opaque, airless packaging (and replace it once it turns brown), and patch-test first if you're prone to contact allergy. As with any brightening routine, daily SPF is non-negotiable — pigment returns without it.

05 / Questions

Frequently asked

Tranexamic acid or kojic acid for dark spots — which is better?
They work at opposite ends of the pigment pathway, so the better pick depends on your goal. Tranexamic acid has the strongest evidence of any non-hydroquinone topical for melasma and uniquely calms the redness/vascular component, and it's gentle and stable — the better standalone for melasma and sensitive skin. Kojic acid is a potent, direct tyrosinase inhibitor with real melasma evidence (a 58% MASI drop at 12 weeks in one trial), but it's less stable and more sensitising, so it shines most as part of a combination routine. For many people the answer is both, in one formula. 49
Why does my kojic acid serum turn brown — and does tranexamic acid do that?
Kojic acid is unstable in water: it oxidises on exposure to light, air and especially iron, forming yellow-to-brown coloured complexes — a visible sign the active has degraded and lost potency, so a discoloured kojic acid product should be replaced. Tranexamic acid doesn't have this problem; it stays above 97% potency for weeks in solution and doesn't discolour, which is one of its practical advantages as a brightener. 136
Can I use tranexamic acid and kojic acid together?
Yes — because they act on different steps (tranexamic acid on the upstream signal and blood vessels, kojic acid on the tyrosinase enzyme), they complement each other rather than overlap. A serum combining tranexamic acid, kojic acid and niacinamide produced significant improvement in facial dyschromia in a clinical evaluation. Use a well-formulated combination or layer them, keep the kojic acid in opaque packaging, patch-test if you're sensitivity-prone, and wear daily SPF. 15

06 / References

Sources

16 references · verified 2026-06-15
  1. 1

    Topical trans-4-aminomethylcyclohexanecarboxylic acid prevents ultraviolet radiation-induced pigmentation

    Maeda K, Naganuma M · Journal of Photochemistry and Photobiology B 47(2-3):136-41 · 1998

  2. 2

    Tranexamic Acid Inhibits Angiogenesis and Melanogenesis in Vitro by Targeting VEGF Receptors

    Zhu JW, Ni YJ, Tong XY, Guo X, Wu XP, Lu ZF · International Journal of Medical Sciences 17(7):903-911 · 2020

  3. 3

    Whitening effects of cosmetic formulation in the vascular component of skin pigmentation

    Pereira AFC, Igarashi MH, Mercuri M, Pereira AF, Pinheiro ALTA, Silva MS, Facchini G, Eberlin S · Journal of Cosmetic Dermatology 19(1):154-160 · 2020

  4. 4

    Efficacy and Safety of Tranexamic Acid in Melasma: A Meta-analysis and Systematic Review

    Kim HJ, Moon SH, Cho SH, Lee JD, Kim HS · Acta Dermato-Venereologica 97(7):776-781 · 2017

  5. 5
  6. 6

    Stability of Tranexamic Acid Mouth Rinse

    Donnelly RF · International Journal of Pharmaceutical Compounding 22(6):469-474 · 2018

  7. 7

    Development of novel topical tranexamic acid liposome formulations

    Manosroi A, Podjanasoonthon K, Manosroi J · International Journal of Pharmaceutics 235(1-2):61-70 · 2002

  8. 8

    Kojic Acid, a Cosmetic Skin Whitening Agent, is a Slow-binding Inhibitor of Catecholase Activity of Tyrosinase

    Cabanes J, Chazarra S, Garcia-Carmona F · Journal of Pharmacy and Pharmacology 46(12):982-985 · 1994

  9. 9
  10. 10
  11. 11

    Contact allergy to kojic acid in skin care products

    Nakagawa M, Kawai K, Kawai K · Contact Dermatitis 32(1):9-13 · 1995

  12. 12

    Pigmented contact dermatitis due to kojic acid. A paradoxical side effect of a skin lightener

    Romita P, Foti C, Hansel K, Stingeni L · Contact Dermatitis 62(3):182-184 · 2010

  13. 13
  14. 14

    Photostability of naturally occurring whitening agents in cosmetic microemulsions

    Gallarate M, Carlotti ME, Trotta M, Bovo S · International Journal of Pharmaceutics 276(1-2):63-71 · 2004

  15. 15

    Effect of a Tranexamic Acid, Kojic Acid, and Niacinamide Containing Serum on Facial Dyschromia: A Clinical Evaluation

    Garg VK, Sinha S, Sarkar R · Journal of Drugs in Dermatology 21(1):72-76 · 2022

  16. 16

    Opinion on Kojic Acid — SCCS/1637/21, Final version with Corrigendum

    Scientific Committee on Consumer Safety (SCCS), European Commission · European Commission Health and Food Safety — Scientific Committees EW-AQ-23-003-EN-N · 2022